Repurposing of Anti-infectives for the Management of Onchocerciasis using Machine Learning and Protein Docking Studies
Cyril Nii Okai-Kommey Tetteh, Andy Andoh Mensah, Bernice Ampomah, Mahmood Brobbey OppongiD, Michael LarteyiD, Paul Owusu DonkoriD, Kwabena F.M. OpuniiD, Lawrence Asamoah AdutwumiD
Abstract
The discovery of new drugs for the treatment of neglected tropical diseases (NTDs) is hampered by the lack of financial reward associated with their development. A combination of exploratory data analysis, machine learning (ML) and molecular docking studies were used to evaluate 58 anti-infective agents to identify those with the potential to be repurposed for the management of onchocerciasis, an NTD. Out of the 58 test drugs, 14 were predicted by at least five ML models to be useful in managing onchocerciasis. Molecular docking studies using glycine receptor subunit -3, gamma-aminobutyric acid receptor subunit {beta}-3 and glutamate-gated chloride channel of the 14 drugs showed binding affinities comparable to that of doramectin and pyrvinium which are known onchocerciasis drugs. Diminazine, trimetinib, triclabendazole, cridanimod, vandetinib and trametinib were the top agents showing high binding affinities from the molecular docking studies. The binding affinities of diminazine and cridanimod are similar to doramectin and pyrvinium which have demonstrated activity against onchocerciasis. The outcome of this study shows the potential of using these 14 drugs to manage onchocerciasis. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=64 SRC="FIGDIR/small/530155v1_ufig1.gif" ALT="Figure 1"> View larger version (13K): org.highwire.dtl.DTLVardef@10887dorg.highwire.dtl.DTLVardef@170e766org.highwire.dtl.DTLVardef@16819e0org.highwire.dtl.DTLVardef@17b0279_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 0.00
- Field percentile
- 20th percentile
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In silico and in vitro Investigations of Antihelmintic Activities of some Selected Approved Drugs
A. C. Agube, D. L. Ajaghaku, I. C. Uzochukwu·Archives of Community Medicine and Public HealthPeer-reviewed·Nov 27, 2020
- Machine learning, molecular docking and simulation studies reveal Lomitapide, Lodipamide, Zafirlukast, Netupitant and Salmon Calcitonin as potent drug molecules against Chagas disease
Kavya Singh, Navjeet Kaur, Ashish Anand Prabhu·bioRxiv·Aug 6, 2024
- Computational studies of drug repurposing targeting P-glycoprotein mediated multidrug-resistance phenotypes in agents of neglected tropical diseases
Nivedita Jaishankar, Sangeetha Muthamilselvan, Ashok Palaniappan·IntechOpen eBooksPeer-reviewed·Sep 14, 2020
- Screening the Medicines for Malaria Pandemic Response Box chemical library on Caenorhabditis elegans identifies re-profiled candidate anthelmintic drug leads
M. Nick, F. A. Partridge, … D. B. Sattelle·bioRxiv·Aug 10, 2022
- In silico drug repurposing and in vitro validation of cestode fatty acid binding proteins
Santiago Rodrı́guez, Lucas N. Alberca, … Alan Talevi·bioRxiv·Mar 6, 2026
- Development of non-sedating antischistosomal benzodiazepines
M. Y. Mian, D. Sharmin, … J. D. Chan·bioRxiv·Jan 26, 2024